Organon (OGN) Cash from Operations (2020 - 2026)
Organon (OGN) recorded quarterly Cash from Operations of 225000000.0 in Q1 2026, up 59.57% quarter-over-quarter from 141000000.0 in Q4 2025, and up 200.0% on a YoY basis from 75000000.0 in Q1 2025.
Organon (OGN) Cash from Operations (2020 - 2026) Analysis & Trends
Organon's Cash from Operations history runs 7 years deep, the most recent figure standing at 225000000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 200.0% year-over-year to 225000000.0; the TTM figure through Mar 2026 stood at 850000000.0 (down 9.38% YoY), while the FY2025 annual figure was 700000000.0, down 25.45% from the prior year.
- Cash from Operations was 225000000.0 for Q1 2026 at Organon, up from 141000000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 397000000.0 in Q4 2023 to a low of 27000000.0 in Q2 2023.
- Historically, Cash from Operations has averaged 207117647.06 across 5 years, with a median of 220000000.0 in 2025.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations slumped 90.54% in 2022, then soared 1129.63% in 2024.
- A 5-year view of Cash from Operations shows it stood at 267000000.0 in 2022, then surged by 48.69% to 397000000.0 in 2023, then fell by 1.76% to 390000000.0 in 2024, then sank by 63.85% to 141000000.0 in 2025, then surged by 59.57% to 225000000.0 in 2026.
- The last three Cash from Operations figures came in at 225000000.0 (Q1 2026), 141000000.0 (Q4 2025), and 264000000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | 1.82 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | 5.33 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 2.51 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | 3.83 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | 3.92 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | 2.19 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 2.54 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | 2.62 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | 1.10 Bn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 225.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 225.00 Mn |
| Mar 31, 2026 | 225.00 Mn |
| Dec 31, 2025 | 141.00 Mn |
| Dec 31, 2025 | 141.00 Mn |
| Sep 30, 2025 | 264.00 Mn |
| Sep 30, 2025 | 264.00 Mn |
| Jun 30, 2025 | 220.00 Mn |
| Jun 30, 2025 | 220.00 Mn |
| Mar 31, 2025 | 75.00 Mn |
| Mar 31, 2025 | 75.00 Mn |
| Dec 31, 2024 | 390.00 Mn |
| Dec 31, 2024 | 390.00 Mn |
| Sep 30, 2024 | 141.00 Mn |
| Sep 30, 2024 | 141.00 Mn |
| Jun 30, 2024 | 332.00 Mn |
| Jun 30, 2024 | 332.00 Mn |
| Mar 31, 2024 | 76.00 Mn |
| Mar 31, 2024 | 76.00 Mn |
| Dec 31, 2023 | 397.00 Mn |
| Dec 31, 2023 | 397.00 Mn |